Get access to our best features
Get access to our best features
Published 2 months ago

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Summary by Ground News
About 1.5 million Americans suffer from rheumatoid arthritis, a chronic disease. Drugs such as Humira and Enbrel block a molecule called tumor necrosis factor alpha. MyMD-1 can be taken as a tablet, rather than injection or infusion, and its molecules are small.

Bias Distribution

  • 100% of the sources are Center
100% Left

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics